New report highlights the impact of early Grade 1 entry and gender disparities in SA education
Boys entering Grade 1 at the minimum age face higher risks of repetition, while gender disparities widen through to Grade 12 ...
FDA approves new genetic disorder drug
The Food and Drug Administration (FDA) approved a new drug to treat a disorder causing the growth of non-cancerous tumors on ...
UPDATE: SpringWorks Therapeutics Announces FDA Approval of GOMEKLIâ„¢ (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN –– Approval based on positive data ...
Medscape1d
FDA Approves Mirdametinib for Neurofibromatosis Type 1
The kinase inhibitor is now approved for adults and children aged ≥ 2 years with neurofibromatosis type 1 who have unresectable symptomatic plexiform neurofibromas.
Medscape2d
Ocular Surface Reconstruction: Recent Innovations, Surgical Candidate Selection and Postoperative Management
Table 1 pools selected studies comparing tissue types, scaffolding materials, overall success rates and complications. Oral-ocular transplantation studies are included here but its discussion will ...